CIRBP and central nervous system cancer: The results of the CCK8 assay suggested that the overexpression of CIRBP inhibited the proliferation of glioma cells, and this inhibitory effect could be partially reversed using a ferroptosis inhibitor ferrostatin 1 (Figure 5G).